NDC properties for NDC 9 0591-2925
NDC item 00591292530
| NDC 9 | 0591-2925 |
|---|---|
| NDC 10 | 0591-2925-30 |
| NDC Item | 00591292530 |
| packaging | 30 PACKET in 1 CARTON (0591-2925-30) / 1.25 g in 1 PACKET (0591-2925-32) |
| ANDA | ANDA204570 |
| DCSA | CIII |
| Labeler | Actavis Pharma, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2025-07-31 |
| Marketing effective time low | 2021-02-12 |
| Marketing status | COMPLETED |
NDC item 00591292532
| NDC 9 | 0591-2925 |
|---|---|
| NDC 10 | 0591-2925-32 |
| NDC Item | 00591292532 |
| packaging | 1.25 g in 1 PACKET |
| ANDA | ANDA204570 |
| DCSA | CIII |
| Labeler | Actavis Pharma, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2025-07-31 |
| Marketing effective time low | 2021-02-12 |
| Marketing status | COMPLETED |
NDC item 16714096801
| NDC 9 | 16714-968 |
|---|---|
| NDC 10 | 16714-968-01 |
| NDC Item | 16714096801 |
| packaging | 1.25 g in 1 PACKET |
| ANDA | ANDA205781 |
| DCSA | CIII |
| Labeler | Northstar Rx LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-11-06 |
| Marketing status | ACTIVE |
NDC item 16714096802
| NDC 9 | 16714-968 |
|---|---|
| NDC 10 | 16714-968-02 |
| NDC Item | 16714096802 |
| packaging | 30 PACKET in 1 CARTON (16714-968-02) / 1.25 g in 1 PACKET (16714-968-01) |
| ANDA | ANDA205781 |
| DCSA | CIII |
| Labeler | Northstar Rx LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-11-06 |
| Marketing status | ACTIVE |
NDC item 45802028103
| NDC 9 | 45802-281 |
|---|---|
| NDC 10 | 45802-281-03 |
| NDC Item | 45802028103 |
| packaging | 1.25 g in 1 PACKET |
| ANDA | ANDA205781 |
| DCSA | CIII |
| Labeler | Padagis Israel Pharmaceuticals Ltd |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-06-27 |
| Marketing status | ACTIVE |
NDC item 45802028139
| NDC 9 | 45802-281 |
|---|---|
| NDC 10 | 45802-281-39 |
| NDC Item | 45802028139 |
| packaging | 30 PACKET in 1 CARTON (45802-281-39) / 1.25 g in 1 PACKET (45802-281-03) |
| ANDA | ANDA205781 |
| DCSA | CIII |
| Labeler | Padagis Israel Pharmaceuticals Ltd |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-06-27 |
| Marketing status | ACTIVE |
NDC item 45802075403
| NDC 9 | 45802-754 |
|---|---|
| NDC 10 | 45802-754-03 |
| NDC Item | 45802075403 |
| packaging | 1.25 g in 1 PACKET (45802-754-03) |
| ANDA | ANDA204268 |
| DCSA | CIII |
| Labeler | Padagis Israel Pharmaceuticals Ltd |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2018-10-12 |
| Marketing status | ACTIVE |
NDC item 68382036212
| NDC 9 | 68382-362 |
|---|---|
| NDC 10 | 68382-362-12 |
| NDC Item | 68382036212 |
| packaging | 1.25 g in 1 PACKET |
| DCSA | CIII |
| Labeler | Zydus Pharmaceuticals (USA) Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2018-10-12 |
| Marketing status | COMPLETED |
| NDA_AUTHORIZED_GENERIC | NDA022309 |